Methyl-CpG-binding protein 2 (MECP2) mutation type is associated with bone disease severity in Rett syndrome

BACKGROUND: More than 95% of individuals with RTT have mutations in methyl-CpG-binding protein 2 (MECP2), whose protein product modulates gene transcription. The disorder is caused by mutations in a single gene and the disease severity in affected individuals can be quite variable. Specific MECP2 mu...

Descripción completa

Detalles Bibliográficos
Autores principales: Caffarelli, Carla, Gonnelli, Stefano, Pitinca, Maria Dea Tomai, Camarri, Silvia, Al Refaie, Antonella, Hayek, Joussef, Nuti, Ranuccio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995101/
https://www.ncbi.nlm.nih.gov/pubmed/32005172
http://dx.doi.org/10.1186/s12881-020-0960-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6995101/
https://www.ncbi.nlm.nih.gov/pubmed/32005172
http://dx.doi.org/10.1186/s12881-020-0960-2

Ejemplares similares